Fibrinogen levels measured by the dry hematology method are lower than those measured by the Clauss method under a high concentration of heparin

ABSTRACT The activity of fibrinogen has been reported to decrease soon after the onset of major bleeding and to be an important determinant of the final extent of bleeding and postoperative outcome. A device that measures the perioperative fibrinogen level using the dry hematology (DH) method has recently become available. The aim of this study was to compare perioperative fibrinogen levels measured by the DH method with those measured by the conventional Clauss method and to assess the effects of heparin on these measurements. The study included 206 samples from 36 patients undergoing major surgery who received high-dose heparin (HH group, 23 samples), low-dose heparin (LH group, 57 samples), or no heparin (C group, 126 control samples). Each sample was measured using the DH and Clauss methods. After excluding samples outside the effective measurement range, the three study groups (HH group, n=23; LH group, n=49; C group, n=115) were compared. The mean fibrinogen level measured by the DH method in the HH group (87.9 ± 3.1%) was significantly lower than that measured by the Clauss method. There were no significant differences between the fibrinogen measurements obtained by the two methods between the LH and C groups. In patients on high-dose heparin, the mean fibrinogen level measured by the DH method was significantly lower than that measured by the Clauss method. When hemorrhage requires emergency treatment, a method that can measure the fibrinogen level rapidly is important. The DH method may be useful for decision-making with regard to perioperative coagulation factor replacement.

[1]  M. Hayakawa,et al.  Rapid Evaluation of Fibrinogen Levels Using the CG02N Whole Blood Coagulation Analyzer , 2015, Seminars in Thrombosis & Hemostasis.

[2]  Kenichi A. Tanaka,et al.  Fibrinogen Measurements in Plasma and Whole Blood: A Performance Evaluation Study of the Dry-Hematology System , 2015, Anesthesia and analgesia.

[3]  W. Beattie,et al.  The Relationship Between Fibrinogen Levels After Cardiopulmonary Bypass and Large Volume Red Cell Transfusion in Cardiac Surgery: An Observational Study , 2013, Anesthesia and analgesia.

[4]  J. Vincent,et al.  Management of bleeding and coagulopathy following major trauma: an updated European guideline , 2013, Critical Care.

[5]  A. Hanke,et al.  Effects of Fibrinogen Concentrate as First-line Therapy during Major Aortic Replacement Surgery: A Randomized, Placebo-controlled Trial , 2013, Anesthesiology.

[6]  L. Cohn,et al.  Point-of-Care Testing: A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients , 2012, Anesthesiology.

[7]  H. Schöchl,et al.  A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients , 2011, Transfusion.

[8]  J. Vincent,et al.  Management of bleeding following major trauma: an updated European guideline , 2010, Critical care.

[9]  J. Ingerslev,et al.  Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. , 2008, British journal of anaesthesia.

[10]  F. Baghaei,et al.  Plasma fibrinogen level, bleeding, and transfusion after on‐pump coronary artery bypass grafting surgery: a prospective observational study , 2008, Transfusion.

[11]  L. Handolin,et al.  Scandinavian Guidelines — “The Massively Bleeding Patient” , 2008, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[12]  J. Vincent,et al.  Management of bleeding following major trauma: a European guideline , 2007, Critical Care.

[13]  P. Hamilton,et al.  Guidelines on the management of massive blood loss , 2006, British journal of haematology.

[14]  J. Duguid,et al.  Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant , 2004, British journal of haematology.

[15]  G. Lowe,et al.  A Performance Evaluation of Commercial Fibrinogen Reference Preparations and Assays for Clauss and PT-derived Fibrinogen , 2002, Thrombosis and Haemostasis.

[16]  P. Mongan,et al.  Profound Normovolemic Hemodilution: Hemostatic Effects in Patients and in a Porcine Model , 1996, Anesthesia and analgesia.

[17]  E. Vahtera,et al.  Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates , 1995, Anesthesia and analgesia.

[18]  K. Ward,et al.  Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation. , 2010, Resuscitation.